brello health glp-1 Brello Health Announcement | TikTok

On average, completers achieved 11.5% weight loss vs 7.3% for placebo at 56 weeks 1,3,5 ITT-LOCF: 8.1% weight loss for CONTRAVE and 4.9% for placebo 1 Completers lost an average of 25 lb vs 16 lb for placebo at 56 weeks 5 ITT-LOCF: ~18 lb for CONTRAVE and ~11 lb for placebo 1 There was an average decrease of 4.4 inches in waist circumference for completers vs 3.0 inches for placebo 6 ITT-LOCF: Decrease of 3.9 inches for CONTRAVE and 2.7 inches for placebo 1 In another randomized controlled trial (COR-I) with similar average baseline parameters to those for COR-BMOD, endpoint results over 56 weeks in completers/ITT groups for patients taking CONTRAVE (n=296/538) vs placebo (n=290/536), respectively, were mean weight change from baseline (8.1%/5.4% decrease vs 1.8%/1.3%), patients achieving 5% weight loss (62%/42% vs 23%/17%), and mean change in waist circumference (2.7-inch/2.4-inch decrease vs 1.0 inch/1.0 inch)

6 If something feels off, say something

This graphic reveals which states had high price growth, and which didnt

Middle-aged women with symptoms of a viral upper respiratory tract infection are most susceptible to the condition